Publications by authors named "Bernard Pau"

Claim this Profile
E
Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidase.
Ilaria Basile, Afitz Da Silva, Khaled El Cheikh, Anastasia Godefroy, Morgane Daurat, Bernard Pau

J Control Release· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis.
Noëlie Campos, Renier Myburgh, Aude Garcel, Audrey Vautrin, Laure Lapasset, Pauline Fornarelli, Bernard Pau

Retrovirology· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38.
Céline Gongora, Laurent Candeil, Nadia Vezzio, Virginie Copois, Vincent Denis, Bernard Pau

Cancer Biol Ther· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.
Maguy Del Rio, Franck Molina, Caroline Bascoul-Mollevi, Virginie Copois, Frédéric Bibeau, Bernard Pau

J Clin Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of RNA degradation on gene expression profiles: assessment of different methods to reliably determine RNA quality.
Virginie Copois, Frédéric Bibeau, Caroline Bascoul-Mollevi, Nicolas Salvetat, Patrick Chalbos, Bernard Pau

J Biotechnol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assay for measurement of intact B-type natriuretic peptide prohormone in blood.
Isabelle Giuliani, François Rieunier, Catherine Larue, Jean-François Delagneau, Claude Granier, Bernard Pau, Jean-Paul Cristol

Clin Chem· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The knowledge tree bear innovation fruit...].
Bernard Pau

Med Sci (Paris)· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
Christophe Broca, Vincent Breil, Céline Cruciani-Guglielmacci, Michèle Manteghetti, Christine Rouault, Bernard Pau

Am J Physiol Endocrinol Metab· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA.
Isabelle Gourdier, Laure Crabbe, Karine Andreau, Bernard Pau, Guido Kroemer

Oncogene· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications in diabetes and cancer.
Nicolas Chapal, Laurence Molina, Franck Molina, Marion Laplanche, Bernard Pau

Fundam Clin Pharmacol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases.
Laurent Candeil, Isabelle Gourdier, Delphine Peyron, Nadia Vezzio, Virginie Copois, Bernard Pau

Int J Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.
Patricia Boya, Maria Celia Morales, Rosa-Ana Gonzalez-Polo, Karine Andreau, Isabelle Gourdier, Bernard Pau

Oncogene· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A peptide mimetic of an anti-CD4 monoclonal antibody by rational design.
Florence Casset, Florence Roux, Patrick Mouchet, Cedric Bes, Thierry Chardes, Bernard Pau

Biochem Biophys Res Commun· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmaco-proteomic analysis: application of proteomic analysis to the discovery and development of new drugs].
Nicolas Chapal, Marion Laplanche, Gérard Ribes, Bernard Pau, Jérôme Garin

J Soc Biol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptides derived from the two regulatory domains of p53 are recognized by two p53-activating antibodies.
Jean-Michel Portefaix, Maguy Del Rio, Claude Granier, Françoise Roquet, Bernard Pau

Peptides· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma.
Isabelle Gourdier, Maguy Del Rio, Laure Crabbé, Laurent Candeil, Virginie Copois, Bernard Pau

FEBS Lett· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of cardiac troponin I forms in the blood of patients with unstable angina pectoris.
Isabelle Giuliani, Jean-Pierre Bertinchant, Michel Lopez, Henri Coquelin, Claude Granier, Bernard Pau

Clin Biochem· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of anti-p53 antibodies by ELISA using p53 synthetic or phage-displayed peptides.
Jean Michel Portefaix, Cristina Fanutti, Claude Granier, Evelyne Crapez, Richard Perham, Bernard Pau

J Immunol Methods· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis